Oregon Attorney General Ellen Rosenblum and 41 other state Attorneys General reached a $35 million settlement with Pfizer Inc, the parent company of Wyeth Pharmaceuticals Inc., to resolve allegations that Wyeth promoted immunosuppressive drug Rapamune for off-label uses. As one of two lead states in the settlement, Oregon will receive $1.2 million for its consumer protection and education account.
“This settlement sends a united message that large pharmaceutical companies cannot promote off-label drug for uses that haven’t been approved by the Food and Drug Administration,” said Attorney General Rosenblum. “Oregon continues to be a national leader in fighting these bad marketing practices by large companies that know better than to try to skirt regulations, thereby putting consumers at risk.”
Print This Post Email This Post